Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020

SELL
$0.63 - $1.1 $652 - $1,139
-1,036 Closed
0 $0
Q1 2020

May 04, 2020

SELL
$0.68 - $2.14 $15 - $49
-23 Reduced 2.17%
1,036 $1,000
Q4 2019

Feb 04, 2020

BUY
$0.65 - $1.68 $133 - $344
205 Added 24.0%
1,059 $2,000
Q3 2019

Nov 12, 2019

BUY
$1.06 - $1.87 $905 - $1,596
854 New
854 $1,000

About ENDRA Life Sciences Inc.


  • Ticker NDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 63,174,500
  • Market Cap $382M
  • Description
  • ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...
More about NDRA
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.